MR编号 | FR/V/0267/001 |
---|
药品名称 | Eurican CHPPi2-LR |
---|
活性成分 | - canine adenovirus 4.9 GKID50
- canine distemper virus 4.7 GKID50
- canine parainfluenza virus 4.6 GKID50
- canine parvovirus 4.9 GKID50
- leptospira interrogans serogroup canicola 32.0 MALR
- leptospira interrogans serogroup icterohaemorragiae 32.0 MALR
- rabies virus 2.0 IU
|
---|
剂型 | Suspension for injection |
---|
上市许可持有人 | MERIAL |
---|
参考成员国 - 产品名称 | France (FR) Eurican DAPPI-LR |
---|
互认成员国 - 产品名称 | - Germany (DE)
Eurican DAPPi-LR - Spain (ES)
EURICAN MHPPi2-LR - Portugal (PT)
- Greece (GR)
- Poland (PL)
Eurican DHPPi2-LR - Cyprus (CY)
|
---|
许可日期 | 2013/09/25 |
---|
最近更新日期 | 2024/09/05 |
---|
药物ATC编码 | - QI07AJ06 live canine distemper virus + live canine adenovirus + live parainfluenza virus + live canine parvovirus + inactivated rabies + inactivated leptospira
|
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|